R
Robert Gallop
Researcher at West Chester University of Pennsylvania
Publications - 266
Citations - 20875
Robert Gallop is an academic researcher from West Chester University of Pennsylvania. The author has contributed to research in topics: Randomized controlled trial & Cognitive therapy. The author has an hindex of 66, co-authored 244 publications receiving 18743 citations. Previous affiliations of Robert Gallop include University of Ottawa & University of Pennsylvania.
Papers
More filters
Journal ArticleDOI
Differential change in specific depressive symptoms during antidepressant medication or cognitive therapy
Jay C. Fournier,Robert J. DeRubeis,Steven D. Hollon,Robert Gallop,Richard C. Shelton,Jay D. Amsterdam +5 more
TL;DR: It is suggested that medications and cognitive therapy led to different patterns of response to specific symptoms of depression and that the general efficacy of these two well-validated treatments may be driven in large part by changes in cognitive or atypical-vegetative symptoms.
Journal ArticleDOI
Response to tryptophan depletion in major depression treated with either cognitive therapy or selective serotonin reuptake inhibitor antidepressants.
John P. O'Reardon,Mohit P. Chopra,Alexandra Bergan,Robert Gallop,Robert J. DeRubeis,Paul Crits-Christoph +5 more
TL;DR: In this paper, the effects of rapid tryptophan depletion (RTD) in patients treated with either selective serotonin re-uptake inhibitors (SSRIs) or cognitive therapy (CT) were compared.
Response to Tryptophan Depletion in Major Depression Treated with Either Cognitive Therapy or Selective Serotonin Reuptake Inhibitor
TL;DR: The CT group was resistant to the effects of tryptophan depletion, but the SSRI group was not, and theSSRI group experienced significant mood worsening during depletion compared with sham on both the HDRS and the BDI, whereas the CT group did not.
Journal ArticleDOI
Effect of exenatide, sitagliptin, or glimepiride on β-cell secretory capacity in early type 2 diabetes.
Lalitha Gudipaty,Nora K. Rosenfeld,Carissa Fuller,Robert Gallop,Mark H. Schutta,Michael R. Rickels +5 more
TL;DR: After 6 months of treatment, exenatide or sitagliptin had no significant effect on functional β- cell mass as measured by β-cell secretory capacity, whereas glimepiride appeared to enhance β- and α-cell secretion.
Journal ArticleDOI
The effectiveness of clinician feedback in the treatment of depression in the community mental health system.
Mary Beth Connolly Gibbons,John E. Kurtz,Donald Thompson,Rachel A. Mack,Jacqueline K. Lee,Aileen B. Rothbard,Susan V. Eisen,Robert Gallop,Paul Crits-Christoph +8 more
TL;DR: The results indicate that the Community Clinician Feedback System is acceptable to providers and patients of mental health services and has the potential to improve the effectiveness of services for clinically meaningful depression in the community mental health setting.